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Abstract
Background: Brucellosis in livestock causes enormous losses for economies of developing countries and poses a
severe health risk to consumers of dairy products. Little information is known especially on camel brucellosis and
its impact on human health. For surveillance and control of the disease, sensitive and reliable detection methods
are needed. Although serological tests are the mainstay of diagnosis in camel brucellosis, these tests have been
directly transposed from cattle without adequate validation. To date, little information on application of real-time
PCR for detection of Brucella in camel serum is available. Therefore, this study was performed to compare the
diagnostic efficiency of different serological tests and real-time PCR in order to identify the most sensitive, rapid
and simple combination of tests for detecting Brucella infection in camels.
Findings: A total of 895 serum samples collected from apparently healthy Sudanese camels was investigated.
Sudan is a well documented endemic region for brucellosis with cases in humans, ruminants, and camels. Rose
Bengal Test (RBT), Complement Fixation Test (CFT), Slow Agglutination Test (SAT), Competitive Enzyme Linked
Immunosorbant Assay (cELISA) and Fluorescence Polarization Assay (FPA) as well as real-time PCR were used. Our
findings revealed that bcsp31 kDa real-time PCR detected Brucella DNA in 84.8% (759/895) of the examined
samples, of which 15.5% (118/759) were serologically negative. Our results show no relevant difference in sensitivity
between the different serological tests. FPA detected the highest number of positive cases (79.3%) followed by CFT
(71.4%), RBT (70.7%), SAT (70.6%) and cELISA (68.8%). A combination of real-time PCR with one of the used
serological tests identified brucellosis in more than 99% of the infected animals. 59.7% of the examined samples
were positive in all serological tests and real-time PCR. A subpopulation of 6.8% of animals was positive in all
serological tests but negative in real-time PCR assays. The high percentage of positive cases in this study does not
necessarily reflect the seroprevalence of the disease in the country but might be caused by the fact that the
camels were imported from brucellosis infected herds of Sudan, accidentally. Seroprevalence of brucellosis in
camels should be examined in confirmatory studies to evaluate the importance of brucellosis in this animal
species.
Conclusion: We suggest combining bcsp31 real-time PCR with either FPA, CFT, RBT or SAT to screen camels for
brucellosis.
Introduction
Camels are the most robust animal species in produc-
tion and survival under harsh environmental conditions.
Although many pastoral groups and communities
throughout the world depend on camels for their liveli-
hood, the health status of camels has not yet received
proper attention from researchers and scientists. Brucel-
losis is caused by Gram-negative bacteria of the genus
Brucella in man and animals. Brucella taxonomy and
species discrimination rely on biochemical, antigenic,
and metabolic characteristics. Camels are highly suscep-
tible to B. melitensis and B. abortus [1] but camels are
not known to be primary hosts of Brucella. B. melitensis
bv 1-3 is predominantly isolated from sheep and goats,
and B. abortus biovar 1-7 and 9 from cattle and other
Bovidae. Thus, the infection of camel herds depends on
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the Brucella species prevalent in other animal species
sharing the same habitats, and on husbandry methods
[2]. The infection seems to be widespread among
camel herds in Africa and on the Arabian Peninsula
[3]. A comprehensive review on the seroprevalence in
camels has recently been published by this working
group. The clinical signs of brucellosis in camels are
not clearly defined. Many infected camels are silent
carriers of brucellosis. Consumption of Brucella
infected food e.g. milk and meat from camels has led
to a high number of human brucellosis cases and ser-
ious public health problems. Farmers from nomadic
areas believe that raw camel milk has a curative effect
on the digestive system [4].
Classical tests for the diagnosis of brucellosis i.e. cul-
ture and phenotypic characterization, are laborious,
time-consuming, pose the risk of infection, and can
generate discordant results. Isolation of the causing
agent often fails in routine diagnosis. Serological tests
are therefore commonly used for Brucella diagnosis in
cattle and small ruminants especially at herd level, but
cross-reactions with other Gram-negative bacteria are a
major problem. Rose Bengal Test (RBT), Complement
Fixation Test (CFT), and Slow Agglutination Test
(SAT) are widely used for the detection of antibodies to
Brucella spp. The sensitivity of RBT fulfills the require-
ments for surveillance of free areas at flock level but it
is believed that only the combination of RBT and CFT
in infected flocks can obtain accurate individual sensi-
tivity in test-and-slaughter programs [5]. CFT is also
recommended by World Organisation for Animal
Health (OIE) as a test prescribed for international trade
[6]. The CFT is recognized as a good test when cor-
rectly performed, but it has many practical drawbacks:
it is cumbersome, time consuming and difficult to stan-
dardize [7]. None of the above mentioned tests can dis-
tinguish between antibodies produced after vaccination
and those due to infection [8]. Different enzyme-linked
immunosorbent assays (ELISA) have been developed to
overcome these problems. Additionally, ELISA could
detect Brucella carriers which were seronegative by
RBT, SAT and CFT [9].
The fluorescence polarisation assay (FPA) is a recently
described test used for the serological diagnosis of Bru-
cella infection. It is a rapid, homogenous, species-inde-
pendent assay, which was initially developed and
validated for the detection of antibodies to B. abortus in
cattle. FPA has many methodological advantages over
the older, more established tests. It has yet to become
established within the routine testing procedures of
most National Brucellosis Reference Laboratories [10].
The FPA requires minimal manipulations and can be
completed in few minutes [11]. It is assumed that sero-
logical tests used for Brucella infection in cattle may
also be adequate for diagnosis of brucellosis in camels.
However, no validation for camel sera was done yet.
Nucleic acid amplification methods might circumvent
the diagnostic window being presented before produc-
tion of specific antibodies. Real-time PCR offers
improved sensitivity, specificity and speed of perfor-
mance when compared to conventional PCR.
The present study was made to compare different ser-
ological tests and real-time PCR to define a rapid and
simple technique capable of specifically detecting Bru-
cella infection in camels.
Materials and methods
Samples
A total of 895 serum samples were received from Cen-
tral Veterinary Research Laboratory (CVRL), Dubai,
UAE. These samples were collected from apparently
healthy camels (Camelus dromedaries) which were
imported from Sudan at the end of 2008 and the begin-
ning of 2009.
Serological tests
All camel serum samples were tested by RBT, SAT,
CFT, cELISA and FPA. Antigens used for RBT, SAT,
and CFT were supplied by Institute Pourquier, France.
Positive and negative control sera are the national refer-
ence sera standardized according to OIE. Positive con-
trol sera contain 421 I.U. per milliliter for SAT and 595
International CFT Units (ICFTU) per milliliter for CFT.
RBT was conducted as described in the Manual of Stan-
dards for Diagnostic Tests and Vaccines [12] using anti-
gen obtained from Institute Pourquier, France. SAT was
performed in microtiter plates [13]. Samples showing
more than 30 I.U. per milliliter were considered positive.
The reagents used in the CFT were standardized and
the test was performed according to OIE [12]. Any
serum showing a value ≥ 20 ICFTU per milliliter was
considered positive. The cELISA was done and results
were interpreted according to the instructions of the
manufactures using Svanovir™ Brucella-Ab cELISA kit
(Svanovia Biotech AB Uppsala, Sweden). FPA was done
and results were interpreted according to the instruc-
tions of the manufacturer (Diachemix, Whitefish Bay,
WT, USA).
Briefly, the test protocols used in our study are the
same as used for bovine brucellosis. Also serum dilution
for FPA was chosen according to the manufacturer’s
protocol for bovine brucellosis. The positive control
serum was of bovine origin.
DNA preparation
DNA was purified using the High pure PCR Template
preparation Kit ™ (Roche Diagnostics, Mannheim, Ger-
many) according to the instructions of the
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manufacturer. 200 μl of serum were used in the assay.
Subsequently, the concentration of DNA was deter-
mined photometrically using a Nano Drop ND-1000
UV-Vis spectrophotometer (Nano-Drop Technologies,
Wilmington, DE, USA).
Real-Time PCR
Real-time PCR for the genus specific Brucella cell
surface salt extractable bcsp31 kDa protein gene was
performed on DNA extracted from camel serum
samples using the following primers (5’GCTCGGTT
GCCAATATCAATGC 3 ’) as forward primer and
(5’GGGTAAAGCGTCGCCAGAAG 3’) as reverse pri-
mer together with genus specific probe (5 ’6FAM-
ACTCCAGAGCGCCCGACTTGATCG-DB 3’) [14].
The primers and probes were obtained from TIB
MOLBIOL (Berlin, Germany). The real-time PCR assay
was prepared using the TaqMan™ Universal Master
Mix (Applied Biosystems, New Jersey USA) containing
the following components per reaction: 12.5 μl Taq-
Man™ Universal Master Mix (Applied Biosystems),
0.75 μl of each primer (0.3 μM) and 0.25 μl probe (0.1
μM). 2 μl of bacterial DNA was used as target and
nuclease-free water sum up to a total reaction volume
of 25 μl. No Template Controls (NTC) that contained
2 μl of water instead of DNA and positive controls
that contained DNA of Brucella were included in each
run to detect any amplicon contamination or amplifi-
cation failure. The real-time PCR reaction was per-
formed in duplicate in optical 96-well microtitre plates
(q PCR 96-well plates, Micro Amp TM, Applied Bio-
system) using a Mx3000P thermocycler system (Strata-
gene, La Jolla, Canada) with the following run
condition 1 cycle of 50°C for 2 min, 1 cycle of 95°C
for 10 min, followed by 50 cycles of 95°C for 25 s and
57°C for 1 min. The extracted DNA from the bcsp31
positive samples were examined with the Brucella
IS711 species specific real-time PCRs for B. abortus
and B. melitensis using the primers and probe as
described previously [14] for typing. Amplification
reaction mixtures were prepared in volumes of 25 μl
containing 12.5 μl TaqMan™ Universal Master Mix
(Applied Biosystems) 0.75 μl of each primer (0.3 μM)
and 0.5 μl TaqMan probe (0.2 μM), 5 μl of template,
and nuclease-free water sum up to a total reaction
volume of 25 μl. Optimisation resulted in reaction con-
dition of 2 min at 50°C, 10 min at 95°C, followed by 50
cycles of 95°C for 15 s and 57°C for 1 min. Cycle
threshold values below 40 cycles were interpreted as
positive. The threshold was set automatically by the
instrument. The samples scored positive by the instru-
ment were additionally confirmed by visual inspection
of the graphical plots showing cycle numbers versus
fluorescence values.
Analytic Sensitivity
To determine the linear measuring range, five replicates
of six 10 fold serial dilutions of B. abortus DNA in
negative camel sera were assessed simultaneously in a
single run. To determine the limit of detection, a probit
analysis was performed using SPSS for Windows (Ver-
sion 8.01, SPSS Inc., Chicago, USA). The probit analysis
was applied to determine the number of genome equiva-
lents that can be detected with a probability of 95%.
Therefore, probit analysis was performed with the result
of 8 replicates of the following amount of DNA per
reaction: 1 pg, 100 fg, 50 fg, 20 fg, 10 fg, 5 fg and 1 fg,
carried out on three different days. Based on the full
bacterial genome sequence of B. melitensis published in
GenBank (accession numbers NC_003317 and
NC_003318), it was determined that each Brucella gen-
ome copy (i.e., genome equivalent [GE]) amounts to
3.38 fg according to the following equation: GE (fg) =
number of base pairs per GE × 618 g mol-1 × 1015/6.023
× 1023 mol-1 (Avogadro constant). The data were also
used to determine repeatability and reproducibility of
the assay.
Statistical analysis
Data analyses were carried out using a statistical soft-
ware program (SPSS for Windows, Version 17.01, SPSS
Inc., Chicago, USA). The agreement between different
serological tests was calculated using Kappa analysis.
As no gold standard was available we performed
Latent Class Analysis (LCA) with all test results. The
latent class model could not be applied for two subpo-
pulations with different prevalences because samples
from only one camel population were available, i.e. the
camels imported from Sudan to UAE in 2008. However,
we constructed a latent class model based on the status
of “Brucella infection” (infected versus not infected ani-
mals) which can be regarded as a pseudo-gold standard
or as presumed true status of infection with two latent
classes. Using contingency tables and percentage agree-
ments we determined total, positive, and negative corre-
lation among test results and the latent class. The
correlation was assessed using the Chi-Square test.
Latent class analysis was conducted with R version 2.13
using the e1071 library.
Results
FPA showed the highest number of positive samples 710
(79.3%), while 639 (71.4%), 633 (70.7%), 632 (70.6%) and
616 (68.8%) samples were found to be positive for bru-
cellosis with CFT, RBT, SAT and cELISA, respectively
(Table 1).
Out of 895 examined sera, 595 (66.5%) were positive
and 170 (19.0%) were negative by all serological tests. 72
(8.04%) were found to be positive by FPA only. 15
Gwida et al. BMC Research Notes 2011, 4:525
http://www.biomedcentral.com/1756-0500/4/525
Page 3 of 7
samples showed false negative results by cELISA. The
real-time PCR assay amplified the Brucella cell surface
salt extractable genus specific bcsp31 kDa protein gene
in 84.8% (759/895) samples. B. abortus was the only spe-
cies found using species specific real-time PCR assays
published by Probert et al. (2004). 534 out of 895
(59.7%) were positive by all serological tests and bcsp31
real-time PCR. 118 (13.2%) were positive by bcsp31 real-
time PCR but negative in all serological tests. We
observed no obvious correlation between the CT values
reflecting DNA concentration with the results obtained
in serological assays (data not shown). 61 (6.8%) samples
were positive by serological tests but negative by bcsp31
real-time PCR (Table 1). The agreement between the
results obtained by FPA and that for bcsp31 real-time
PCR is illustrated in (Table 2). FPA was positive in 626
samples out of 759 (82.5%) that were positive by bcsp31
real-time PCR. A probit analysis revealed that real-time
PCR assay detect as little as 23 fg (corresponding
approximately 7 GE) of Brucella DNA per reaction with
a probability of 95%.
The presence of Brucella DNA as demonstrated by
bcsp31 real-time PCR or presence of anti Brucella anti-
bodies proved by two different serological tests was con-
sidered as proof for a potential risk of consumers when
consuming products of these animals. The panel of sera
which fulfill at least one of these criteria was considered
to be the “gold standard”. According to this definition
(positive by real-time PCR or two different serological
tests) 828 samples had to be considered as “true” posi-
tive. Real-time PCR detects 759 samples out of 828 with
a sensitivity of 91.7%. The sensitivity of RBT, cELISA,
CFT, SAT and FPA was 76.5, 74.4, 77.2, 76.3 and 83.9%,
respectively. The LCA model with two classes showed a
good fit (BIC = 2931.761) for two latent classes, which
demonstrates that the underlying correlation structure
can be well explained by two latent classes.
Real-time PCR had a high sensitivity but low specifi-
city in relation to the latent class, whereas the serologi-
cal tests all showed very high sensitivity and specificity
(Table 3). The Chi-Square test showed a highly signifi-
cant correlation of all tests with the latent class (p <
1012 or lower).
Discussion
Control of brucellosis in livestock and humans depends
on the reliability of the methods used for detection and
identification of the causative agent. However, diagnosis
of brucellosis in camels is frequently difficult. The dis-
ease can mimic many infectious and non infectious dis-
eases. Characteristic clinical signs of brucellosis in
camels are often lacking and diagnostic methods are not
evaluated yet. In the present study, all camels were clini-
cally normal at the time of sampling and according to
the owners, none had previously shown clinical signs of
brucellosis. Theses results indicate that many infected
camels might be silent carriers for brucellosis and their
products may pose a serious health problem for consu-
mers. Our observations are supported by a study [15]
demonstrating that non pregnant camels experimentally
infected with a field strain of B. abortus had no clinical
signs and only negligible pathological changes were pre-
sent. The authors found also that the organism was
recovered mainly from the lymph nodes of the head and
genital tract. However, single cases of abortion, placental
retention, fetal death, mummification, delayed sexual
maturity, infertility, stillbirth, mastitis, orchitis and joint
disease have been reported from camels naturally
Table 1 Number of positive results per test used for the
detection of brucellosis in asymptomatic camels
Sample n = 895 RTPCR RBT cELISA CFT SAT FPA
534 534 534 534 534 534 534
118 118 - - - - -
57 57 - - - - 57
15 15 15 - 15 15 15
5 5 - - 5 - 5
4 4 4 4 4 - 4
4 4 4 4 4 4 -
3 3 - 3 3 3 3
3 3 3 3 - 3 -
3 3 3 - - 3 -
2 2 2 2 2 2
2 2 - - - 2 2
2 2 2 - 2 2 -
1 1 1 - - - 1
1 1 1 - 1 - 1
1 1 - - 1 1 1
1 1 - 1 1 1
1 1 1 - 1 - -
1 1 1 1 - - -
1 1 - - - 1 -
61 - 61 61 61 61 61
15 - - - - - 15
4 - - - 4 - 4
2 - - 2 2 - 2
1 - 1 - - - 1
1 - - 1 1 1 1
52 - - - - - -
Total n = 895 759 633 616 639 632 710
Percent % 84.8 70.7 68.8 71.4 70.6 79.3
Real-time PCR BCSP31 (Real Time Polymerase Chain Reaction, Brucella Cell
Surface Protein 31 kDa, RBT (Rose Begnal Test), SAT(Slow Agglutination Test),
CFT (Complement Fixation Test), cELISA (Competitive Enzyme Linked
Immunosorbant Assay), FPA (Fluorescence Polarization Assay).
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infected with B. abortus [16]. Having in mind these facts,
a camel posing a risk for consumers was considered
either to have Brucella DNA in its blood samples or
being positive for the presence of antibodies confirmed
by two independent serological test systems. Animals
that are positive for DNA only may be in the incubation
period before an antibody titer develops or may simply
be unable to produce specific antibodies at all.
Serological tests can detect infection when sepsis has
passed and the agent has found its niche in the host.
The obtained results revealed that 79.3, 71.4, 70.7, 70.6
and 68.8% of the camel sera investigated were positive
by FPA, CFT, RBT, SAT and cELISA, respectively. CFT
detected more positive cases than agglutination tests.
This result is in agreement with that previously reported
[17,18]. These authors stated that the complement fixa-
tion test is the most widely used test for brucellosis
screening in camels. Only little information was avail-
able in the literature on the application of cELISA on
camel serum [18,19]. Various studies, however, have
confirmed that ELISA techniques perform better than
other conventional tests used for serological screening
of brucellosis in other animal species [20]. Our results
revealed that 616 camel serum samples out of 828
(74.4%) were positive by cELISA, demonstrating the
lowest sensitivity when compared to other serological
tests. This may be attributed to the fact that cELISA
was specially standardized to work with bovine sera or
the very special presentation of brucellosis in camels. It
has to be stressed that sensitivity and specificity may
vary considerably if another cELISA will be tested. To
the best of our knowledge, FPA has not been used for
the diagnosis of camel brucellosis yet. Our results
revealed that FPA detected more positive cases than all
other serological tests used. Thus, FPA seems to be a
valuable tool for the diagnosis of brucellosis in camels
especially when taking into consideration the speed, the
objectivity of result interpretation and the cost factor.
FPA could be considered as a senseful replacement for
other established methods. Further studies are now
needed to assess FPA’s reproducibility. A perfect agree-
ment between CFT, RBT and SAT was proven by calcu-
lating Kappa values but sensitivity of all tests is low
when compared to FPA or real-time PCR. It is advisable
to combine at least two serological test methods to
screen brucellosis on herd level. This finding is in accor-
dance with the procedure of monitoring in other animal
Table 2 Comparative analysis for the results of serological test and real-time PCR
Sample RBT cELISA CFT SAT FPA
Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg
Bcsp31 Pos (n = 759) 571 188 552 207 571 188 570 189 626 133
Neg
(n = 136)
62 74 64 72 68 68 62 74 84 52
RBT Pos
(n = 633)
609 24 622 11 624 9 619 14
Neg
(n = 262)
7 255 17 245 8 254 91 171
cELISA Pos
(n = 616)
610 6 608 8 608 8
Neg
(n = 279)
29 250 24 255 102 177
CFT Pos
(n = 639)
621 18 632 7
Neg
(n = 256)











Real-time PCR 72 90 28
RBT 99 99 97
cELISA 97 97 99
CFT 98 99 95
SAT 99 99 98
FPA 89 99 67
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species. Thus, the sensitivity will be increased. Never-
theless, serological methods used solitary or in combi-
nation carry the risk to miss seronegative carriers of
Brucella.
Real-time PCR proved to be a valuable diagnostic tool
when culture fails or serological results are inconclusive
in human brucellosis [20]. It is faster and more sensitive
than culture. The risk of transmission of brucellosis to
laboratory workers can be minimized. To the best of
our knowledge real-time PCR has not been previously
used for diagnosis of camel brucellosis. Interestingly,
real-time PCR targeting the genus specific bcsp31 was
positive in 84.8% out of 895 samples demonstrating the
presence of the agent within the animal. It cannot be
concluded that these camels are permanently infected,
although brucellosis tends to have a chronic course.
However, these animals may be asymptomatic carriers
and shedders. They pose a permanent risk to other ani-
mals and humans and have to be removed from the
herd.
534 samples out of 895 (59.7%) were positive in all
serological tests and real-time PCR. The high percentage
of positive animals detected by real-time PCR could be
attributed to the high diagnostic sensitivity of the real-
time PCR assay to detect as little as 23 fg of Brucella
DNA per reaction with a probability of 95%. Real-time
PCR detected also infection in 118 seronegative camels
which prompts us to conclude that these were probably
acute or chronically infected animals with antibody
levels not yet or no longer detectable. While PCR
directly detects the DNA of the pathogen, serology is
dependent upon the rising and falling titers of antibo-
dies during the different phases of brucellosis. Conse-
quently, real-time PCR is the test to complement
diagnosis of camel brucellosis. We suggest that conven-
tional PCR could be used in developing countries
because of the lower costs and the high amount of Bru-
cella DNA in the blood of infected camels in contrast to
other animal species. 15.2% (136/895) of samples were
negative by real-time PCR. These samples include 61
which were seropositive in our study. In fact, this sub-
population is smaller than expected, because this con-
stellation would indicate a passed infection without
circulating DNA but antibodies present in serum. On
the herd level a high number of chronic infections
would have a negative impact on the usability of real-
time PCR as a screening tool, but it may have advan-
tages in acute cases when there is bacteremia but no
immunological response or clinical picture yet. The sto-
rage time can negatively influence the presence of
detectable DNA as well as the antibody concentration.
A storage time of up to one year as occured in our
study might have some influence on the performance of
the assays.
Assuming that the two latent classes truly reflect the
infection status of the animals the LCA results indicate
that the real-time PCR has the worst performance. The
serological tests all perform concordant and very well.
However, the LCA cannot answer the question, whether
the real-time PCR provides false positive results or
whether in certain cases all other tests provide the
wrong result. As the LCA per se has no preference for a
single method, the serological results may dominate and
will bias the overall result. In our view the biological
interpretation is that in early infection all serological
tests are still negative and the PCR assays are true posi-
tive while in passed infections the pathogen DNA has
been eliminated by the organism. So in acute infections
real-time PCR is a relevant and useful method while in
chronic and passed infection seroconversion is signifi-
cantly more reliable. With regard to consumer protec-
tion the LCA analysis does not help to estimate the
value of a single diagnostic test. In our interpretation
the presence of Brucella DNA justifies the removal of
animals according to OIE guidelines.
The high percentage of positive cases might be caused
by the fact that the camels were imported from Sudan
where a high prevalence of camel brucellosis is known
[21-23]. Nevertheless, seroprevalence of brucellosis in
camels has to be examined in confirmatory studies to
evaluate the importance of the disease in camel popula-
tion. Isolation of B. abortus from free ranging camelids
in Sudan was already reported [2,17].
In accordance a species specific real-time PCR system
revealed that only B. abortus was present in the serum
of the camels investigated in this study. It can be sup-
posed that a spill over from cattle was the origin for this
findings and the spread of disease was promoted by the
crowding situation during transport. This fact does not
ensure that these camels are infected with B. abortus
only since B. melitensis was isolated from camels of the
same origin earlier (data not shown).
Conclusion
In developed countries, a combination of real-time PCR
with at least one serological method preferably FPA
could be applied to detect brucellosis in camels. In less
developed countries a combination of conventional PCR
with one of the commonly used serological tests (i.e.
RBT, SAT, CFT) can be recommended. Camels have to
be included in national programs for control and eradi-
cation of brucellosis in endemic countries.
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